Peptide modifications change the formula and mass: an amide end is 0.98 Da lighter, an acetyl cap adds 42.01 Da, a disulfide removes 2.02 Da, and D-amino acids change nothing in mass.
For laboratory research use only. Not for human or animal use. This page covers chemistry, identity and paperwork only. It gives no use, preparation or administration instructions.
Many peptides in our catalog are not plain chains of the 20 standard amino acids. Small changes at the ends or in the chain change the formula, the mass and how the peptide behaves in testing. This page explains the common ones, with examples from our catalog and the mass change each causes.
| Modification | What changes | Mass change | Effect | Catalog examples |
|---|---|---|---|---|
| C-terminal amide | -COOH becomes -CONH2 | -0.98 Da | Removes the negative charge at the C-terminus. | CJC-1295 (no DAC), Ipamorelin, Sermorelin, Tesamorelin, GHRP-2 (Pralmorelin), GHRP-6, Oxytocin |
| N-terminal acetylation | Acetyl group (CH3CO-) on the N-terminal amine | +42.01 Da | Removes the positive charge at the N-terminus. | TB-500 (Thymosin Beta-4), P21 (P021), Thymosin Alpha-1 |
| Pyroglutamate (pGlu) | N-terminal Gln or Glu closes into a ring | -17.03 Da from Gln; -18.01 Da from Glu | No free N-terminal amine. | ARA-290, Thymulin |
| Disulfide bridge | Two Cys side chains joined S-S | -2.02 Da | Locks a loop or ring. | AOD-9604, Oxytocin |
| D-amino acids | Mirror-image residue in place of the L form | 0 Da | Changes shape and resistance to enzymes; invisible to MS. | CJC-1295 (no DAC), Ipamorelin, GHRP-2 (Pralmorelin), GHRP-6, FOXO4-DRI |
| Retro-inverso | Whole sequence reversed and built from D-residues | 0 Da vs the forward D-sequence | Keeps side chains in a similar layout. | FOXO4-DRI |
| Non-standard residues | Aib, 2-naphthylalanine, adamantane-based residues | Varies | Calculators that only know 20 amino acids will be wrong; use the formula. | Ipamorelin, P21 (P021), GHRP-2 (Pralmorelin) |
| Fatty acyl cap | Hexenoyl or hexanoyl group on the N-terminus | +96.06 Da (trans-3-hexenoyl) | Adds hydrophobic character. | Tesamorelin, Dihexa |
| Maleimide (DAC) group | Maleimidopropionyl on an extra lysine | see CJC-1295 with DAC | A reactive group added to the chain. | CJC-1295 with DAC |
| Metal complex | Copper(II) held by the peptide | + Cu, charge changes | Coloured (blue) and can lose copper in MS. | GHK-Cu |
| Gamma (isopeptide) bond | Glu linked through its side-chain carboxyl | 0 Da vs the alpha-linked isomer | Same formula as the normal link, different structure. | Glutathione |
Mass changes are monoisotopic and worked out from the atoms added or removed. All can be specified in a custom synthesis project; see the custom peptide synthesis process.
Why modifications matter on a certificate
- The expected mass must include every modification, or a correct result will look wrong.
- A peak at the unmodified mass (for example 42 Da light for a missing acetyl, 0.98 Da heavy for acid instead of amide) points to incomplete modification.
- D-amino acids and isomers need methods other than MS to confirm.
Related pages
- Amino acid reference table
- How peptide molecular weight is calculated
- Compound chemistry index (all structure and COA pages)
- Compound reference table: CAS, formula and MW for every compound
- Purity grades, HPLC and mass spec explained
- How batch quarantine and release works
- COA lot lookup: find any lot’s certificate
Common questions
What does -NH2 at the end of a peptide sequence mean?
The C-terminus is an amide instead of a free acid. It is 0.98 Da lighter and has no negative charge at that end.
What does Ac- mean at the start of a sequence?
The N-terminal amine carries an acetyl group, which adds 42.01 Da and removes the positive charge there.
Can mass spec detect D-amino acids?
No. D and L forms weigh the same; chiral chromatography or other methods are needed.
Research use only. Not for human or animal use. Simple Life Science is operated by Melex Technologies Inc., 6586 W Atlantic Ave Ste #1112, Delray Beach, FL 33446.